Lp(a): Closer Than You Think [CE Podcast]
Kathy Byrne, MSN, CRNP, CCRN.,and Lisa Maher, DNP, ARNP, FNP-BC, FPCNA, describe the most common genetic dyslipidemia–elevated lipoprotein (a), or Lp(a). The discussion includes testing for Lp(a)–especially cascade screening for…
Read MoreLurking Lp(a): Hiding Just Below the Surface [CE Podcast]
While Lp(a) levels are generally hereditary in nature, other factors can cause elevated levels. Learn about current guidelines-directed medical therapies, and how Lisa Maher, DNP, ARNP, FNP-BC, FPCNA, and Kathy…
Read MoreThe Buck Stops Here: We’re All Responsible for Lp(a) [CE Podcast]
Cindy Lamendola, MSN, NP, FAHA, FPCNA, describes the impacts of elevated Lp(a) on the body. Current clinical trials and the necessity of including diverse participants are described, as well as…
Read MoreWe’re All Responsible for Lp(a)
Guest Cindy Lamendola, MSN, NP, FAHA, FPCNA, describes the impacts of elevated Lp(a) on the body. Current clinical trials and the necessity of including diverse participants are described, as well…
Read MoreLurking Lp(a): Hiding Just Below the Surface
While Lp(a) levels are generally hereditary in nature, other factors can cause elevated levels. Learn about current guidelines-directed medical therapies, and how guests Lisa Maher, DNP, ARNP, FNP-BC, FPCNA, and…
Read MoreLp(a): Closer to Home Than You Think
Guests Kathy Byrne, MSN, CRNP, CCRN.,and Lisa Maher, DNP, ARNP, FNP-BC, FPCNA, describe the most common genetic dyslipidemia–elevated lipoprotein (a), or Lp(a). The discussion includes testing for Lp(a)–especially for family…
Read MoreInherited Genetic Lipid Disorders: An Overview
In this course, you’ll hear from both a clinician and a patient living with familial hypercholesterolemia on the effects of dyslipidemia. Review dyslipidemia, its pathophysiology, effects, and pharmacological management with…
Read MoreAccess to Lipid Lowering Medications
Join Dr. Handberg to review novel lipid-lowering medications on the market today and examine the effect of social determinants of health on access and adherence to lipid-lowering medications. Patient Advocate…
Read MoreWomen’s Lipid Health Across the Lifespan: An Unmet Need
Join Dr. Gianos in a discussion of women’s lipid health, including lipids during the peri-pregnancy period and dyslipidemia treatment considerations for contraception and fertility. You’ll also learn about the effects…
Read MoreThe Latest Strategies in Dyslipidemia Diagnosis and Management
Dyslipidemia, the imbalance of low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein (HDL), triglycerides, and other lipids, is one of the major modifiable risk factors for atherosclerosis and cardiovascular disease (CVD).1 With…
Read More